A new development in Rochester, known as The Ridge phase 2, is planned to include housing, commercial buildings, and a hospital emergency department. Developers are seeking a permit recommendation ...

The Microscopic and Digital One-Day-Dentistry Concept is a new and cutting-edge workflow, first time published by Dr. Behnam Shakibaie and his research team at the University of Pennsylvania, that ...

CARMEL, Ind. — Portions of I-465 and U.S. 31 will be impacted in Carmel starting in early October as the Indiana Department of Transportation begins its latest road improvement project. According to a ...

ALLEN PARK -- The Detroit Lions have placed starting cornerback D.J. Reed on injured reserve. Reed suffered a hamstring injury during Sunday’s win over the Cleveland Browns. It didn’t take long for ...

There have been whispers this week that the Edmonton Oilers and Jake Walman are nearing a finalization of a deal that would keep the defenseman in Edmonton long-term. Several sources have indicated ...

While working on a research paper, I decided to test one of the leading AI assistants and asked Anthropic’s Claude to analyze hundreds of emails and build a spreadsheet of recent Nobel Prize-winners.

Justin Fields is progressing towards a return on Monday night. The fifth-year quarterback practiced on Thursday, but remains in concussion protocol, according to Jets coach Aaron Glenn. “He still has ...

It was a highly momentous and joyful occasion for the whole country and the royal family—though few were more excited than young Princess Charlotte. Charlotte was just eight-years-old when she ...

Beijing QL Biopharmaceutical has shared phase 2 data on its once-monthly GLP-1 candidate, providing early evidence that the ultra-long-acting prospect can match the efficacy of weekly products from ...

IPN10200 is a recombinant, first-in-class molecule uniquely engineered to generate increased receptor affinity and internalization that produces a longer duration of action, optimized for safety and ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...